New drug combo shows promise for tough cancers
Disease control
Completed
This phase 2 trial tested a combination of two drugs—telatinib (a pill that blocks tumor blood vessels) and Keytruda (an immunotherapy that helps the immune system attack cancer)—in 16 people with advanced stomach, gastroesophageal junction, or liver cancer. The goal was to see i…
Phase: PHASE2 • Sponsor: Andrew Hendifar, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC